Skip to main content
SpringerLink
Log in

An Overview to Ankylosing Spondylitis and Spondyloarthropathies

  • Chapter
  • First Online:
Ankylosing Spondylitis - Axial Spondyloarthritis

  • 894 Accesses

Abstract

Spondyloarthropathies (SpAs) are a debilitating group of chronic autoimmune diseases that affect a considerable proportion of young adults causing medical, social, and economical consequences. The prominent feature of SpAs is positive familial history and presence of HLA-B27 in most patients, which suggests genetic predisposing factors in disease pathogenesis. Ankylosing Spondylitis (AS), being the most prevalent and severe form of SpAs, is generally characterized by inflammatory low back pain accompanied by radiological findings of sacroiliitis. Despite all radiological and laboratory advancements, the complicated manifestations of AS urges for multi-factorial diagnostic criteria evolved during recent years for efficient detection and follow-up of the patients. According to the inflammatory base of SpAs, various anti-inflammatory medications have been used for treating the patients ranging from nonsteroidal anti-inflammatory drugs to Disease-modifying anti-rheumatic drugs, including synthetic and biologic agents. In the present chapter, we provide a general overview of epidemiologic, diagnostic, pathophysiologic, and therapeutic aspects of Spondyloarthropathies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ruffer MA. Studies in the Palaeopathology of Egypt. Chicago: University of Chicago Press; 1921.

    Google Scholar 

  2. Colombo M. De Re Anatomica. Venice; 1559. This case cited by every French medical writer on hermaphrodites, p. 268–9.

    Google Scholar 

  3. Von Bechterew W. Steifigkeit der Wirbelsäule und ihre Verkrümmung als besondere Erkrankungsform. Neurologisches Zentralblatt. 1893;12:426–34.

    Google Scholar 

  4. Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum dis. 2002;61(Suppl 3):iii8–iii18.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Moll JH, Haslock I, Macrae IF, Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter’s disease, the intestinal arthropathies, and Behcet’s syndrome. Medicine (Baltimore). 1974;53:343–64.

    Article  CAS  Google Scholar 

  6. Rudwaleit M, Haibel H, Baraliakos X, Listing J, Märker-Hermann E, Zeidler H, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis inception cohort. Arthritis Rheumatism: Official Journal of the American College of Rheumatology. 2009;60(3):717–27.

    Article  CAS  Google Scholar 

  7. Akkoç N, Khan MA. Chapter 3 – Epidemiology of axial spondyloarthritis. In: Mease P, Khan MA, editors. Axial spondyloarthritis, Amsterdam. Elsevier; 2019. p. 31–56.

    Chapter  Google Scholar 

  8. Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford, England). 2014;53(4):650–7. https://doi.org/10.1093/rheumatology/ket387.

    Article  Google Scholar 

  9. Solomon L, Beighton P, Valkenburg HA, Robin G, Soskolne CL. Rheumatic disorders in the south African negro. Part I. rheumatoid arthritis and ankylosing spondylitis. S Afr Med J =uid-Afrikaanse tydskrif vir geneeskunde. 1975;49(32):1292–6.

    CAS  Google Scholar 

  10. Mikkelsen WM, Dodge HJ, Duff IF, Kato H. Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959-60. J Chronic Dis. 1967;20(6):351–69.

    Article  CAS  PubMed  Google Scholar 

  11. Stolwijk C, van Onna M, Boonen A, van Tubergen A. Global prevalence of Spondyloarthritis: a systematic review and Meta-regression analysis. Arthritis Care Res. 2016;68(9):1320–31. https://doi.org/10.1002/acr.22831.

    Article  Google Scholar 

  12. Hukuda S, Minami M, Saito T, Mitsui H, Matsui N, Komatsubara Y, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan ankylosing spondylitis society. J Rheumatol. 2001;28(3):554–9.

    CAS  PubMed  Google Scholar 

  13. Videm V, Thomas R, Brown MA, Hoff M. Self-reported diagnosis of rheumatoid arthritis or ankylosing spondylitis has low accuracy: data from the Nord-Trondelag health study. J Rheumatol. 2017;44(8):1134–41. https://doi.org/10.3899/jrheum.161396.

    Article  PubMed  Google Scholar 

  14. Wang R, Ward MM. Epidemiology of axial spondyloarthritis: an update. Curr Opin Rheumatol. 2018;30(2):137–43. https://doi.org/10.1097/bor.0000000000000475.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Polley HF, Slocumb CH. Rheumatoid spondylitis: a study of 1,035 cases. Ann Intern Med. 1947;26(2):240–9.

    Article  CAS  PubMed  Google Scholar 

  16. Bodur H, Ataman Ş, Buğdaycı DS, Rezvani A, Nas K, Uzunca K, et al. Description of the registry of patients with ankylosing spondylitis in Turkey: TRASD-IP. Rheumatol Int. 2012;32(1):169–76.

    Article  PubMed  Google Scholar 

  17. Baumberger H, Khan M. SAT0417 gradual progressive change to equal prevalence of ankylosing spondylitis among males and females in Switzerland: data from the swiss ankylosing spondylitis society (SVMB). London: BMJ Publishing Group; 2017.

    Google Scholar 

  18. Rusman T, van Vollenhoven R, van der Horst-Bruinsma I. Gender differences in axial spondyloarthritis: women are not so lucky. Curr Rheumatol Rep. 2018;20(6):35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973;288(14):704–6.

    Article  CAS  PubMed  Google Scholar 

  20. Geirsson AJ, Kristjansson K, Gudbjornsson B. A strong familiality of ankylosing spondylitis through several generations. Ann Rheum Dis. 2010;69(7):1346–8.

    Article  PubMed  Google Scholar 

  21. Nasution A, Mardjuadi A, Kunmartini S, Suryadhana N, Setyohadi B, Sudarsono D, et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J Rheumatol. 1997;24(6):1111–4.

    CAS  PubMed  Google Scholar 

  22. Geczy AF, Alexander K, Bashir HV, Edmonds JP, Upfold L, Sullivan J. HLA-B27, Klebsiella and ankylosing spondylitis: biological and chemical studies. Immunol Rev. 1983;70(1):23–50.

    Article  CAS  PubMed  Google Scholar 

  23. Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B, et al. Brief report: intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol. 2015;67(3):686–91.

    Article  PubMed  Google Scholar 

  24. Breban M, Tap J, Leboime A, Said-Nahal R, Langella P, Chiocchia G, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis. Ann Rheum Dis. 2017;76(9):1614–22.

    Article  CAS  PubMed  Google Scholar 

  25. Lindström U, Exarchou S, Lie E, Dehlin M, Forsblad-d’Elia H, Askling J, et al. Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study. Arthritis Res Ther. 2016;18(1):240.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Braun J, Kingsley G, Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th international workshop on reactive arthritis, Berlin, Germany, July 3–6, 1999. J Rheumatol. 2000;27(9):2185–92.

    CAS  PubMed  Google Scholar 

  27. Ward MM, Reveille JD, Learch TJ, Davis JC Jr, Weisman MH. Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis. Arthritis Care & Research: Official Journal of the American College of Rheumatology. 2008;59(6):822–32.

    Article  Google Scholar 

  28. Thorarensen SM, Lu N, Ogdie A, Gelfand JM, Choi HK, Love TJ. Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2017;76(3):521–5.

    Article  PubMed  Google Scholar 

  29. Videm V, Cortes A, Thomas R, Brown MA. Current smoking is associated with incident ankylosing spondylitis—the HUNT population-based Norwegian health study. J Rheumatol. 2014;41(10):2041–8.

    Article  PubMed  Google Scholar 

  30. Poddubnyy D, Listing J, Haibel H, Knüppel S, Rudwaleit M, Sieper J. Functional relevance of radiographic spinal progression in axial spondyloarthritis: results from the GErman SPondyloarthritis inception cohort. Rheumatology. 2018;57(4):703–11.

    Article  CAS  PubMed  Google Scholar 

  31. Fallahi S, Mahmoudi M, Nicknam MH, Gharibdoost F, Farhadi E, Saei A, Nourijelyani K, Ahmadzadeh N, Jamshidi AR. Effect of HLA-B* 27 and its subtypes on clinical manifestations and severity of ankylosing spondylitis in Iranian patients. Iranian Journal of Allergy, Asthma and Immunology. 2013:321–30.

    Article  PubMed  Google Scholar 

  32. Sepriano A, Rudwaleit M, Sieper J, van den Berg R, Landewé R, van der Heijde D. Five-year follow-up of radiographic sacroiliitis: progression as well as improvement? Ann Rheum Dis. 2016;75(6):1262–3.

    Article  PubMed  Google Scholar 

  33. Khan M, Khan M, Kushner I. Survival among patients with ankylosing spondylitis: a life-table analysis. J Rheumatol. 1981;8(1):86–90.

    CAS  PubMed  Google Scholar 

  34. Exarchou S, Lie E, Lindström U, Askling J, Forsblad-d’Elia H, Turesson C, et al. Mortality in ankylosing spondylitis: results from a nationwide population-based study. Ann Rheum Dis. 2016;75(8):1466–72.

    Article  PubMed  Google Scholar 

  35. Mok C, Kwok C, Ho L, Chan P, Yip S. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong. China Arthritis Rheumatism. 2011;63(5):1182–9.

    Article  CAS  PubMed  Google Scholar 

  36. Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis. 2011;70(11):1921–5.

    Article  PubMed  Google Scholar 

  37. Wysham KD, Murray SG, Hills N, Yelin E, Gensler LS. Cervical spinal fracture and other diagnoses associated with mortality in hospitalized ankylosing spondylitis patients. Arthritis Care Res. 2017;69(2):271–7.

    Article  Google Scholar 

  38. Fauny M, Albuisson E, Bauer E, Perrier-Cornet J, Chary-Valckenaere I, Loeuille D. Study of vertebral fracture and scanographic bone attenuation coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls. Sci Rep. 2019;9(1):13323. https://doi.org/10.1038/s41598-019-49712-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Khan MA. Chapter 2 – Clinical features, physical findings, and diagnosis of axial spondyloarthritis. In: Mease P, Khan MA, editors. Axial Spondyloarthritis. Amsterdam: Elsevier; 2019. p. 9–29.

    Chapter  Google Scholar 

  40. Khan MA. Ankylosing spondylitis. Oxford: Oxford University Press; 2009.

    Google Scholar 

  41. Khan MA. Update on spondyloarthropathies. Ann Intern Med. 2002;136(12):896–907.

    Article  PubMed  Google Scholar 

  42. de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18(1):196.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Jacques P, Lambrecht S, Verheugen E, Pauwels E, Kollias G, Armaka M, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2014;73(2):437–45.

    Article  PubMed  Google Scholar 

  44. El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011;22(6):554–60. https://doi.org/10.1016/j.ejim.2011.06.006.

    Article  PubMed  Google Scholar 

  45. Robertson LP, Davis MJ. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology. 2004;43(12):1565–8. https://doi.org/10.1093/rheumatology/keh386.

    Article  CAS  PubMed  Google Scholar 

  46. Brophy S, Pavy S, Lewis P, Taylor G, Bradbury L, Robertson D, et al. Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors. J Rheumatol. 2001;28(12):2667–73.

    CAS  PubMed  Google Scholar 

  47. Rademacher J, Poddubnyy D, Pleyer U. Uveitis in spondyloarthritis. Ther Adv Musculoskelet Dis. 2020;12:1759720X20951733. https://doi.org/10.1177/1759720X20951733.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Krishna U, Ajanaku D, Denniston AK, Gkika T. Uveitis: a sight-threatening disease which can impact all systems. Postgrad Med J. 2017;93(1106):766–73. https://doi.org/10.1136/postgradmedj-2017-134891.

    Article  CAS  PubMed  Google Scholar 

  49. Kiwalkar S, Rosenbaum JT, Schwartzman S, Dutz JP, Van den Bosch F. Chapter 11 Extraarticular manifestations uveitis, colitis, psoriasis. In: Axial spondyloarthritis. Amsterdam: Elsevier; 2019. p. 157–82.

    Chapter  Google Scholar 

  50. Khan MA, Haroon M, Rosenbaum JT. Acute anterior uveitis and spondyloarthritis: more than meets the eye. Curr Rheumatol Rep. 2015;17(9):59.

    Article  PubMed  CAS  Google Scholar 

  51. Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis. 2008;67(7):955–9. https://doi.org/10.1136/ard.2007.075754.

    Article  CAS  PubMed  Google Scholar 

  52. Max R, Lorenz H, Mackensen F. Ocular involvement in spondyloarthropathies: HLA B27 associated uveitis. Z Rheumatol. 2010;69(5):397–402.

    Article  CAS  PubMed  Google Scholar 

  53. Mielants H, Veys E, Goemaere S, Goethals K, Cuvelier C, De MV. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol. 1991;18(10):1542–51.

    CAS  PubMed  Google Scholar 

  54. De Cruz P, Kamm M, Hamilton A, Ritchie K, Gorelik A, Liew D, et al. P342 Adalimumab prevents post-operative Crohn’s disease recurrence and is superior to thiopurines: Early results from the prospective POCER study. Journal of Crohn’s and Colitis. 2012;6(Supplement_1):S146.

    Article  Google Scholar 

  55. Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017;63(4):278–85.

    PubMed  PubMed Central  Google Scholar 

  56. Deodhar A, Gensler LS, Sieper J, Clark M, Calderon C, Wang Y, et al. Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis. Arthritis Rheumatol. 2019;71(2):258–70.

    Article  CAS  PubMed  Google Scholar 

  57. Baeten D, Østergaard M, Wei JC-C, Sieper J, Järvinen P, Tam L-S, et al. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Ann Rheum Dis. 2018;77(9):1295–302.

    Article  CAS  PubMed  Google Scholar 

  58. Vinsonneau U, Brondex A, Mansourati J, Saraux A, Cornily JC, Arlès F, et al. Cardiovascular disease in patients with spondyloarthropathies. Joint Bone Spine. 2008;75(1):18–21. https://doi.org/10.1016/j.jbspin.2007.04.011.

    Article  PubMed  Google Scholar 

  59. Jeandel P, Bonnet D, Chouc P, Molinier S, Raphenon G, Martet G, et al. Demonstration of subclinical pulmonary alveolitis in spondylarthropathies. Revue du rhumatisme (Ed francaise: 1993). 1994;61(5):301–9.

    CAS  Google Scholar 

  60. Sampaio-Barros PD, Cerqueira EMF, Rezende SM, Maeda L, Conde RA, Zanardi VA, et al. Pulmonary involvement in ankylosing spondylitis. Clin Rheumatol. 2007;26(2):225–30.

    Article  PubMed  Google Scholar 

  61. Ward MM. Chapter 12 – Comorbidities*. In: Mease P, Khan MA, editors. Axial Spondyloarthritis. Amsterdam: Elsevier; 2019. p. 183–202.

    Chapter  Google Scholar 

  62. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004;63(5):535–43. https://doi.org/10.1136/ard.2003.011247.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43(8):761.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Gonzalez-Roces S, Alvarez M, Gonzalez S, Dieye A, Makni H, Woodfield DG, et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens. 1997;49(2):116–23.

    Article  CAS  PubMed  Google Scholar 

  65. López-Larrea C, Sujirachato K, Mehra NK, Chiewsilp P, Isarangkura D, Kanga U, et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis evidence for new associations. Tissue Antigens. 1995;45(3):169–76.

    Article  PubMed  Google Scholar 

  66. Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, De Vlam K, Mielants H, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol. 1999;26(4):980–4.

    CAS  PubMed  Google Scholar 

  67. Maksymowych WP, RGW L. Chapter 10 – Imaging in axial spondyloarthriti. In: Mease P, Khan MA, editors. Axial Spondyloarthritis. Amsterdam: Elsevier; 2019. p. 135–55.

    Chapter  Google Scholar 

  68. Bidad K, Salehi E, Jamshidi A, Saboor-Yaraghi AA, Oraei M, Meysamie A, Mahmoudi M, Nicknam MH. Effect of alltransretinoic acid on Th17 and T regulatory cell subsets in patients with ankylosing spondylitis. The Journal of rheumatology. 2013;40(4):476–83.

    Article  PubMed  Google Scholar 

  69. Bazzocchi A, Aparisi Gomez MP, Guglielmi G. Conventional radiology in Spondyloarthritis. Radiol Clin N Am. 2017;55(5):943–66. https://doi.org/10.1016/j.rcl.2017.04.003.

    Article  PubMed  Google Scholar 

  70. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–8. https://doi.org/10.1002/art.1780270401.

    Article  PubMed  Google Scholar 

  71. Geijer M, Göthlin GG, Göthlin JH. The clinical utility of computed tomography compared to conventional radiography in diagnosing sacroiliitis. A retrospective study on 910 patients and literature review. J Rheumatol. 2007;34(7):1561–5.

    PubMed  Google Scholar 

  72. Devauchelle-Pensec V, d’Agostino MA, Marion J, Lapierre M, Jousse-Joulin S, Colin D, et al. Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: results of a prospective multicenter French cohort study. Arthritis Rheum. 2012;64(5):1412–9.

    Article  PubMed  Google Scholar 

  73. de Koning A, de Bruin F, van den Berg R, Ramiro S. Low-dose CT detects more progression of bone formation in comparison to conventional radiography in patients with ankylosing spondylitis: results from the SIAS cohort. Ann Rheum Dis. 2018;77(2):293–9. https://doi.org/10.1136/annrheumdis-2017-211989.

    Article  CAS  PubMed  Google Scholar 

  74. Puhakka KB, Jurik AG, Schiottz-Christensen B, Hansen GVO, Egund N, Christiansen JV, et al. Magnetic resonance imaging of sacroiliitis in early seronegative spondylarthropathy. Abnormalities correlated to clinical and laboratory findings. Rheumatology. 2003;43(2):234–7. https://doi.org/10.1093/rheumatology/keh008.

    Article  PubMed  Google Scholar 

  75. Navarro-Compán V, Deodhar A. Chapter 4 – Classification criteria for axial spondyloarthritis. In: Mease P, Khan MA, editors. Axial Spondyloarthritis. Amsterdam: Elsevier; 2019. p. 57–65.

    Chapter  Google Scholar 

  76. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA. 1977;237(24):2613–4. https://doi.org/10.1001/jama.1977.03270510035017.

    Article  CAS  PubMed  Google Scholar 

  77. Linden SVD, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27(4):361–8.

    Article  PubMed  Google Scholar 

  78. Amor B, Dougados M, Listrat V, Menkes C, Dubost J, Roux H, et al. Evaluation of the Amor criteria for spondylarthropathies and European Spondylarthropathy Study Group (ESSG). A cross-sectional analysis of 2,228 patients. Annales de medecine interne. 1991;142:85–9.

    CAS  PubMed  Google Scholar 

  79. Rudwaleit M, Feldtkeller E, Sieper J. Easy assessment of axial spondyloarthritis (early ankylosing spondylitis) at the bedside. Ann Rheum Dis. 2006;65(9):1251–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. van den Berg R, de Hooge M, Rudwaleit M, Sieper J, van Gaalen F, Reijnierse M, et al. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis caught early (SPACE)-cohort and from the assessment of SpondyloArthritis international society (ASAS)-cohort. Ann Rheum Dis. 2013;72(10):1646–53.

    Article  PubMed  Google Scholar 

  81. Rudwaleit M, Van Der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–83.

    Article  CAS  PubMed  Google Scholar 

  82. Mv R, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou C, et al. The assessment of SpondyloArthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70(1):25–31.

    Article  Google Scholar 

  83. Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index. J Rheumatol. 1994;21(12):2281–5.

    CAS  PubMed  Google Scholar 

  84. Magrey MN, Kiltz U. Chapter 9 – clinical assessment of axial spondyloarthritis. In: Mease P, Khan MA, editors. Axial spondyloarthritis. Amsterdam: Elsevier; 2019. p. 121–33.

    Chapter  Google Scholar 

  85. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21(12):2286–91.

    CAS  PubMed  Google Scholar 

  86. Rezaiemanesh A, Abdolmaleki M, Abdolmohammadi K, Aghaei H, Pakdel FD, Fatahi Y, et al. Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomed & Pharmacoth = Biomedecine & pharmacotherapie. 2018;100:198–204. https://doi.org/10.1016/j.biopha.2018.01.108.

    Article  CAS  Google Scholar 

  87. Stockwin LH, McGonagle D, Martin IG, Blair GE. Dendritic cells: immunological sentinels with a central role in health and disease. Immunol Cell Biol. 2000;78(2):91–102. https://doi.org/10.1046/j.1440-1711.2000.00888.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Wright PB, McEntegart A, McCarey D, McInnes IB, Siebert S, Milling SWF. Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammation. Rheumatology. 2015;55(1):120–32. https://doi.org/10.1093/rheumatology/kev245.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Zambrano-Zaragoza JF, Agraz-Cibrian JM, González-Reyes C, Durán-Avelar M, Vibanco-Pérez N. Ankylosing spondylitis: from cells to genes. Int J Inflamm. 2013;2013:501653.

    Article  CAS  Google Scholar 

  90. Bresnihan B, Pontifex E, Thurlings RM, Vinkenoog M, El-Gabalawy H, Fearon U, et al. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. J Rheumatol. 2009;36(8):1800–2. https://doi.org/10.3899/jrheum.090348.

    Article  PubMed  Google Scholar 

  91. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 1995;38(4):499–505.

    Article  CAS  Google Scholar 

  92. Mousavi T, Poormoghim H, Moradi M, Tajik N, Shahsavar F, Soofi M. Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients. Iran J Allergy Asthma Immunol. 2009;8(4):193–8.

    CAS  PubMed  Google Scholar 

  93. Boyington JC, Sun PD. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol Immunol. 2002;38(14):1007–21. https://doi.org/10.1016/S0161-5890(02)00030-5.

    Article  CAS  PubMed  Google Scholar 

  94. Limón-Camacho L, Vargas-Rojas MI, Vázquez-Mellado J, Casasola-Vargas J, Moctezuma JF, Burgos-Vargas R, et al. In vivo peripheral blood Proinflammatory T cells in patients with ankylosing spondylitis. J Rheumatol. 2012;39(4):830–5. https://doi.org/10.3899/jrheum.110862.

    Article  PubMed  Google Scholar 

  95. Xueyi L, Lina C, Zhenbiao W, Qing H, Qiang L, Zhu P. Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti− TNF-α therapy. J Clin Immunol. 2013;33(1):151–61.

    Article  PubMed  CAS  Google Scholar 

  96. Busquets-Perez N, Marzo-Ortega H, Emery P. Emerging drugs for axial spondyloarthritis including ankylosing spondylitis. Expert Opin Emerg Drugs. 2013;18(1):71–86. https://doi.org/10.1517/14728214.2013.752815.

    Article  CAS  PubMed  Google Scholar 

  97. Niu X-Y, Zhang H-Y, Liu Y-J, Zhao D, Shan Y-X, Jiang Y-F. Peripheral B-cell activation and exhaustion markers in patients with ankylosing spondylitis. Life Sci. 2013;93(18–19):687–92.

    Article  CAS  PubMed  Google Scholar 

  98. Voswinkel J, Weisgerber K, Pfreundschuh M, Gause A. B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection. Arthritis Res Ther. 2001;3(3):189.

    Article  CAS  Google Scholar 

  99. Ge L, Wang J, Zhu BQ, Zhang ZS. Effect of abnormal activated B cells in patients with ankylosing spondylitis and its molecular mechanism. Eur Rev Med Pharmacol Sci. 2018;22(9):2527–33. https://doi.org/10.26355/eurrev_201805_14941.

    Article  CAS  PubMed  Google Scholar 

  100. Chan A, Filer A, Parsonage G, Kollnberger S, Gundle R, Buckley CD, et al. Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2008;58(3):707–17.

    Article  CAS  Google Scholar 

  101. Barthel C, Yeremenko N, Jacobs R, Schmidt RE, Bernateck M, Zeidler H, et al. Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis. Arthritis Res Ther. 2009;11(3):R82.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  102. Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, et al. American College of Rheumatology/spondylitis Association of America/Spondyloarthritis research and treatment network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68(2):282–98.

    Article  PubMed  Google Scholar 

  103. van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978–91.

    Article  PubMed  Google Scholar 

  104. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet (London, England). 2002;359(9313):1187–93. https://doi.org/10.1016/s0140-6736(02)08215-6.

    Article  CAS  Google Scholar 

  105. Van den Bosch F, Carron P, Mease P. Chapter 15 – biologic treatment of axial spondyloarthritis. In: Mease P, Khan MA, editors. Axial spondyloarthritis. Amsterdam: Elsevier; 2019. p. 227–42.

    Chapter  Google Scholar 

  106. Carron P, Van Praet L, Jacques P, Elewaut D, Van den Bosch F. Therapy for spondyloarthritis: the role of extra-articular manifestations (eye, skin). Rheum Dis Clin N Am. 2012;38(3):583–600. https://doi.org/10.1016/j.rdc.2012.08.017.

    Article  Google Scholar 

  107. Braun J, Baraliakos X, Deodhar A, Poddubnyy D, Emery P, Delicha EM, et al. Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study. Rheumatology. 2018;58(5):859–68. https://doi.org/10.1093/rheumatology/key375.

    Article  CAS  PubMed Central  Google Scholar 

  108. van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, et al. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial. Lancet (London, England). 2018;392(10163):2441–51. https://doi.org/10.1016/s0140-6736(18)31946-9.

    Article  CAS  Google Scholar 

  109. Braun J, Kiltz U, Heldmann F, Baraliakos X. Emerging drugs for the treatment of axial and peripheral spondyloarthritis. Expert Opin Emerg Drugs. 2015;20(1):1–14.

    Article  CAS  PubMed  Google Scholar 

  110. Ritchlin C, Rahman P, Kavanaugh A, McInnes IB, Puig L, Li S, et al. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial. Ann Rheum Dis. 2014;73(6):990–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Sara Assadiasl & Narjes Soleimanifar

Authors
  1. Sara Assadiasl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Narjes Soleimanifar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Narjes Soleimanifar .

Editor information

Editors and Affiliations

  1. Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Mohammad Hossein Nicknam

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Assadiasl, S., Soleimanifar, N. (2022). An Overview to Ankylosing Spondylitis and Spondyloarthropathies. In: Nicknam, M.H. (eds) Ankylosing Spondylitis - Axial Spondyloarthritis. Springer, Singapore. https://doi.org/10.1007/978-981-16-4733-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-4733-8_1

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-4732-1

  • Online ISBN: 978-981-16-4733-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation